• Science & Technology
• Health & Medicine

News digest – lung cancer screening study, 100,000 genomes sequenced, NHS proton beam therapy and a ‘universal cancer blood test’

In this week’s news: why a ‘universal cancer test’ is not yet ready for patients and the UK’s largest ever lung cancer screening study will open next year. In this week’s news: why a ‘universal cancer test’ is not yet ready for patients and the UK’s largest ever lung cancer screening study will open next year.

8 December 2018

• Science & Technology

Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology

This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments. This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.

30 November 2018

• Health & Medicine

Nobel Prize 2018: how the winning chemistry technique helped generate new cancer treatments

Professor George Smith and Sir Gregory Winter won a Nobel Prize for a developing a technique that can help scientists discover new cancer drugs. Professor George Smith and Sir Gregory Winter won a Nobel Prize for a developing a technique that can help scientists discover new cancer drugs.

17 October 2018

• Health & Medicine

NHS England to fund engineered cell therapy for adults with aggressive lymphoma

A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.

5 October 2018

• Health & Medicine

Nobel Prize 2018: How Allison and Honjo turned immune cells against cancer

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer. Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

1 October 2018

• Health & Medicine

Urine liquid biopsies could help monitor bladder cancer treatment

Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment. Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.

26 September 2018

• Science & Technology
• Health & Medicine

News digest – Stoptober, NHS drug decisions, quality calories and the childhood cancer survivor turned scientist

In this week’s news: a pathologist shortage is causing delays to cancer diagnosis and PHE launches its annual Stoptober campaign. In this week’s news: a pathologist shortage is causing delays to cancer diagnosis and PHE launches its annual Stoptober campaign.

22 September 2018

• Health & Medicine

Liver cancer: UK’s fastest rising cause of cancer death to be tackled

A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK. A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.

20 September 2018

• Health & Medicine

European cancer research gets £30 million vote of confidence

Cancer Research UK is partnering with two of Europe’s leading cancer research charities to fund six international projects worth a total of around £30 million. Cancer Research UK is partnering with two of Europe’s leading cancer research charities to fund six international projects worth a total of around £30 million.

20 September 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for aggressive adult lymphoma on NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.

19 September 2018

• Health & Medicine

London biotherapeutics powerhouse launched by Cancer Research UK

The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment. The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment.

17 September 2018

• Health & Medicine

Making chemotherapy kinder for childhood leukaemia

Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder. Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.

14 September 2018